ArticleKorean circulation journal2025
Physical Growth Trajectories in Children With Congenital Heart Disease: A Nationwide Study.
Article in Korean circulation journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Observational
- Growth in Children with Congenital Heart Disease: Filling the Gap With Nationwide Evidence.Korean circulation journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectivesThe growth trajectories of children diagnosed with congenital heart disease (CHD) remain unclear when analyzed through population-based data. This study examined the risk of poor growth outcomes in preschool-aged children with CHD.
methodsThis study included 325,930 children born between 2007 and 2014, of whom 65,186 were diagnosed with CHD (1,026 with complex, 2,073 with moderate, and 62,087 with simple CHD). Growth Z-scores (height, weight, head circumference, and body mass index) were measured through the National Health Screening Program for Infants and Children, which is conducted annually for children aged six months to six years. Participants were observed until death or December 31, 2020, whichever occurred first.
resultsOverall, there were 1,390 deaths in the CHD group, with a cumulative survival rate of 97.9%. Growth deficits were most pronounced in the complex CHD group, followed by the moderate and simple CHD groups, as well as the normal control groups (short stature at 4-6 years of age: 10.7% vs. 8.9% vs. 5.9% vs. 2.4%, p<0.001). Growth curves illustrated that patients with complex CHD experience persistent height and weight impairments throughout the preschool period. The β estimate (standard error) of height was -0.432 standard deviation score (SDS) (0.041) for the complex CHD group, -0.343 SDS (0.028) for the moderate CHD group, and -0.200 SDS (0.005) for the simple CHD group.
conclusionsChildren with CHD showed poor growth outcomes throughout the preschool period. We highlight the importance of longitudinal growth surveillance for high-risk children with CHD during this period to mitigate the development of health issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.